Overview / Abstract: |
Target Audience The intended audience for this activity are hematologists, primary care providers, pediatricians, obstetricians, gynecologists, family physicians, internists, physician assistants, nurse practitioners, and other HCPs involved in the management of patients with von Willebrand disease. Learning Objectives At the conclusion of this activity, participants will be able to: Distinguish von Willebrand disease (VWD) among varied clinical presentations and laboratory assays to improve timely diagnosis |
Expiration |
Jan 14, 2022 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty David Lillicrap, MD Robert F. Sidionio, Jr., MD, MSc |
Sponsors / Supporters / Grant Providers |
Takeda Pharmaceuticals U.S.A, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FREECME., von Willebrand Disease Free CE CME |